Mayne Pharma Group Ltd (MYX.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Sales | 406,510 | 387,904 | 182,390 | 423,915 | 400,321 |
| Cost of Goods | 160,821 | 169,624 | 100,099 | 253,769 | 205,577 |
| Gross Profit | 245,689 | 218,280 | 82,291 | 170,146 | 194,744 |
| Operating Expenses | 295,799 | 357,590 | 272,962 | 253,287 | 194,055 |
| Operating Income | -50,110 | -139,310 | -190,671 | -83,141 | 689 |
| Interest Expense | 39,359 | 34,501 | 28,389 | 32,098 | 32,347 |
| Other Income | 6,173 | -16,276 | -50,638 | -102,579 | -232,229 |
| Pre-tax Income | -83,296 | -190,087 | -269,698 | -217,818 | -263,887 |
| Income Tax | 6,775 | -21,468 | 47,745 | 56,132 | -54,805 |
| Net Income Continuous | -90,071 | -168,619 | -317,443 | -273,950 | -209,082 |
| Net Income Discontinuous | -3,765 | -5,614 | 434,600 | N/A | N/A |
| Minority Interests | N/A | N/A | 92 | 10,607 | 659 |
| Net Income | $-93,836 | $-174,233 | $117,249 | $-263,343 | $-208,423 |
| EPS Basic Total Ops | -1.19 | -2.12 | 1.42 | -3.20 | -2.65 |
| EPS Basic Continuous Ops | -1.14 | -2.19 | -3.86 | -3.20 | -2.65 |
| EPS Basic Discontinuous Ops | -0.05 | -0.07 | 5.28 | 0.00 | 0.00 |
| EPS Diluted Total Ops | -1.19 | -2.12 | 1.42 | -3.20 | -2.65 |
| EPS Diluted Continuous Ops | -1.14 | -2.19 | -3.86 | -3.20 | -2.65 |
| EPS Diluted Discontinuous Ops | -0.05 | -0.07 | 5.28 | 0.00 | 0.00 |
| EBITDA(a) | $25,329 | $-87,127 | $-175,868 | $-104,639 | $-163,352 |